MARATHON UNKNOWN

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-02-27 for MARATHON UNKNOWN manufactured by Micro Therapeutics, Inc. Dba Ev3.

Event Text Entries

[181766746] The marathon catheter will not be returned for evaluation as it was discarded by the customer; therefore, no definitive conclusion can be drawn regarding the clinical observation. As noted in the marathon ifu:? Infusion pressure with this device should not exceed 690 kpa/100 psi. Pressure in excess of 690 kpa/100 psi may result in catheter rupture, possibly resulting in patient injury. Remove excess slack in the catheter to reduce the potential for catheter kink or prolapse. Verify catheter integrity prior to re-inserting guidewire or injecting embolic material to prevent vascular damage or unintended embolization. Catheter integrity is verified by angiographically confirming that contrast agent is exiting only from the catheter tip while viewing the entire distal section of the catheter.? Related mdrs for this event: 2029214-2020-00168, 2029214-2020-00169. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[181766747] Medtronic received information that one marathon catheter ruptured during onyx injection. The patient underwent embolization treatment for a dural arteriovenous fistula (davf). The vessel was observed moderately tortuous. The marathon microcatheter was delivered to the target site, wash was performed, after 0. 23cc of dmso was injected, when an attempt was made to inject onyx. It was reported that since it was a relatively safe position, after pushing it with a little more force, the rupture occurred at the pinhole at distal region about 4 cm, so the catheter was immediately removed. The catheter was discarded. The remaining vial of the first onyx was retrieved. After that, another catheter (marathon) was used. Another catheter was used, and the procedure was continued. The target site was almost occluded. There was not any patient injury reported. The devices were prepared according to the instructions per the ifu. The delivery catheter cavity filled with dmso. The infusion rate as recommended per the ifu and onyx injection took 2 seconds.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2029214-2020-00169
MDR Report Key9764083
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-02-27
Date of Report2020-02-27
Date of Event2020-02-07
Date Mfgr Received2020-02-07
Date Added to Maude2020-02-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMGR. KATCHA TAYLOR
Manufacturer Street9775 TOLEDO WAY
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone9496801345
Manufacturer G1MICRO THERAPEUTICS, INC. DBA EV3
Manufacturer Street9775 TOLEDO WAY
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal Code92618
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMARATHON
Generic NameCATHETER, CONTINUOUS FLUSH
Product CodeKRA
Date Received2020-02-27
Model NumberUNKNOWN
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerMICRO THERAPEUTICS, INC. DBA EV3
Manufacturer Address9775 TOLEDO WAY IRVINE CA 92618 US 92618


Patients

Patient NumberTreatmentOutcomeDate
10 2020-02-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.